Amicus Therapeutics announces EC approval for Pombiliti™
Congratulations to Amicus Therapeutics for their European Commission approval for Pombiliti™ in patients with Late-Onset...
read Details
Congratulations to Incyte on their FDA approval for Zynyz™, a treatment for adults with metastatic or recurrent locally advanced Merkel cell carcinoma (MCC). Modality Solutions is proud to have been a part of its cold chain strategy!
Congratulations to Amicus Therapeutics for their European Commission approval for Pombiliti™ in patients with Late-Onset...
read DetailsThe team at Acadia Pharmaceuticals Inc. announced FDA Approval on their drug Daybue, for...
read DetailsThe team at Atara Biotherapeutics announced EU Approval on their allogeneic T-cell therapy to treat adult...
read Details